MHRA authorises Onswik (insulin efsitora alfa) for adults with type 2 diabetes
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 13 October 2026, authorised Onswik (insulin efsitora alfa)…
Browsing Category